​

Atara Biotherapeutics Ownership | Who Owns Atara Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Atara Biotherapeutics Ownership Summary


Atara Biotherapeutics is owned by 30.59% institutional investors, 16.55% insiders, and 52.86% retail investors. Ecor1 capital is the largest institutional shareholder, holding 11.02% of ATRA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.05% of its assets in Atara Biotherapeutics shares.

ATRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtara Biotherapeutics30.59%16.55%52.86%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ecor1 capital1.55M11.02%$17.82M
Adage capital partners gp850.00K6.04%$9.76M
Point72 asset management687.72K4.88%$7.90M
Redmile group441.70K3.14%$5.07M
Vanguard group225.94K1.67%$4.09M
Vanguard capital management247.05K1.64%$2.10M
Mackenzie financial176.76K1.18%$1.50M
Blackrock funding, inc. /de85.30K0.57%$725.07K
Geode capital management80.95K0.54%$688.42K
Vanguard fiduciary trust50.70K0.34%$430.98K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ecor1 capital1.55M0.87%$17.82M
Redmile group441.70K0.34%$5.07M
Staley capital advisers50.00K0.02%$425.00K
Adage capital partners gp850.00K0.01%$9.76M
Point72 asset management687.72K0.01%$7.90M
Bridgeway capital management14.00K0.00%$160.72K
Xtx topco15.30K0.00%$175.68K
Mackenzie financial176.76K0.00%$1.50M
Empowered funds13.76K0.00%$116.96K
Employees retirement system of texas5.15K0.00%$44.00K

Top Buyers

HolderShares% AssetsChange
Ecor1 capital1.55M0.87%1.45M
Point72 asset management687.72K0.01%493.45K
Adage capital partners gp850.00K0.01%150.00K
Vanguard group225.94K0.00%22.50K
Ubs group20.76K-16.78K

Top Sellers

HolderShares% AssetsChange
Blackrock---6.83M
Bank of america corp /de/---6.58M
Price t rowe associates inc /md/---4.96M
Aqr capital management---2.63M
Woodline partners lp---1.77M

New Positions

HolderShares% AssetsChangeValue
Xtx topco15.30K0.00%15.30K$175.68K
Empowered funds13.76K0.00%13.76K$116.96K
Employees retirement system of texas5.15K0.00%5.15K$44.00K

Sold Out

HolderChange
Western wealth management-1.00
Nelson, van denburg & campbell wealth management group-23.00
Eversource wealth advisors-35.00
Nisa investment advisors-50.00
Gamma investing-56.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202634-5.56%4,598,9382.93%303.46%14-12.50%912.50%
Jun 30, 2026365.88%4,467,95474.24%319.57%16-5.88%8166.67%
Mar 31, 202633-21.43%2,564,23025.10%208.95%16-15.79%3-62.50%
Dec 31, 20257-81.08%379,045-79.87%21.17%3-81.25%1-85.71%
Sep 30, 20258-73.33%233,049-86.80%10.91%3-62.50%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF120.26K2.05%-
Mackenzie Quantitative US Small Cap167.40K1.86%154.50K
Vanguard Morn Total Stk Mkt Idx Investor158.65K1.76%-
Vanguard Total Stock Mkt Idx Inv158.65K1.76%-
Vanguard MStar Total Stk Mkt Idx Invest158.65K1.58%-
Vanguard Institutional Extnd Mkt Idx Tr82.76K0.88%-
Mackenzie GQE US Small Cap F856.06K0.56%-1.53K
Fidelity Extended Market Index38.47K0.38%-145.00
Bridgeway Ultra-Small Company18.69K0.22%-
iShares Micro-Cap ETF18.51K0.18%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 16, 2026Nguyen AnhCo President and CEOSell$39.37K
Sep 04, 2026Cherry Brian N-Buy$999.99K
Aug 17, 2026Nguyen AnhCo President and CEOSell$40.88K
May 18, 2026Nguyen AnhCo President and CEOSell$47.84K
May 18, 2026Grant-Huerta Yanina Chief Accounting OfficerSell$22.04K

Insider Transactions Trends


DateBuySell
2026 Q4-1
2026 Q311
2026 Q213
2026 Q1-9
2025 Q4-5

ATRA Ownership FAQ


Who Owns Atara Biotherapeutics?

Atara Biotherapeutics shareholders are primarily institutional investors at 30.59%, followed by 16.55% insiders and 52.86% retail investors. The average institutional ownership in Atara Biotherapeutics's industry, Biotech Stocks , is 181.42%, which Atara Biotherapeutics falls below.

Who owns the most shares of Atara Biotherapeutics?

Atara Biotherapeutics’s largest shareholders are Ecor1 capital (1.55M shares, 11.02%), Adage capital partners gp (850K shares, 6.04%), and Point72 asset management (687.72K shares, 4.88%). Together, they hold 21.94% of Atara Biotherapeutics’s total shares outstanding.

Does Blackrock own Atara Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Atara Biotherapeutics.

Who is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Ecor1 capital is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.87% of its assets in 1.55M Atara Biotherapeutics shares, valued at 17.82M$.

Who is the top mutual fund holder of Atara Biotherapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Atara Biotherapeutics shares, with 2.05% of its total shares outstanding invested in 120.26K Atara Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools